MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202617067148 A) filed by Centivax, Inc. on May 28, 2026, for Influenza Vaccines And Uses Thereof.
Inventors include Glanville, Jacob; Bedi, Rishi; Kim, Sangil; Youssef, Sawsan; and Sadoff, Jerald.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: The present disclosure provides amino acid modifications to influenza hemagglutinin (HA) polypeptides for enhanced stability, increased expression yield, enhanced immunogenicity, and/or enhanced expression, or durability of expression, on the cell surface.
Disclaimer: Curated by HT Syndication....